國立虎尾科技大學 |

Cannabis and Cannabinoid-Based Medicines in Cancer Care = A Comprehensive Guide to Medical Management /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Cannabis and Cannabinoid-Based Medicines in Cancer Care/ by Claude Cyr, Mellar P. Davis, Danial Schecter, Paul Daeninck.
Reminder of title:	A Comprehensive Guide to Medical Management /
Author:	Cyr, Claude.
other author:	Davis, Mellar P.
Description:	XXVII, 308 p. 8 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Internal medicine. -
Online resource:	https://doi.org/10.1007/978-3-030-89918-9
ISBN:	9783030899189

Cannabis and Cannabinoid-Based Medicines in Cancer Care = A Comprehensive Guide to Medical Management /
Cyr, Claude.

Cannabis and Cannabinoid-Based Medicines in Cancer CareA Comprehensive Guide to Medical Management /[electronic resource] :by Claude Cyr, Mellar P. Davis, Danial Schecter, Paul Daeninck. - 1st ed. 2022. - XXVII, 308 p. 8 illus. in color.online resource.

Overview of the Endocannabinoid System and Endocannabinoidome -- Cannabinoid-Based Medicine: Pharmacology and Drug Interactions -- Future Therapeutic Potential of Synthetic Cannabinoids and Endocannabinoid System Modulators -- Cannabis-Based Medicines as Anti-Cancer Agents -- Cannabinoid-Based Medicines and Cancer Symptom Management -- Patient Evaluation: Precautions and Managing Expectations -- Choosing a Product, Route of Administration, Initial Dosage, Titration, Monitoring and Management of Adverse Effects -- Psychoactive Effects of Cannabinoid-Based Medicines: Exploration and Inquiry.

The use of cannabinoid-based medicines (CBM), and cannabis in particular, has risen steadily among cancer and palliative care patients over the last few years. This textbook aims to address the multiple challenges facing healthcare providers regarding the use of CBM in this vulnerable patient population. It provides insight into the latest preclinical and clinical data and offers a practical approach on the use of CBM in a rapidly evolving landscape. It answers questions regarding the prescribing process and elucidates controversies regarding cannabis’ disease-modifying effects. The first chapters will review basic concepts of the endocannabinoid system and pharmacology of CBM, while focusing more specifically on the unique characteristics of two main cannabinoids: THC and CBD. Indicating which benefits can be expected from using either or both of these compounds, the book then addresses issues of drug-drug interactions and other challenges involved in prescribing CBM to frail patients with polypharmacy and multiple comorbidities. Comparing available products, both approved and non-approved by the FDA, the book discusses regional challenges for accessing reliably tested and labelled products in the context of standardization efforts. After carefully determining objectives and addressing patient expectations, further chapters will examine the different clinical settings in which CBM may be useful in cancer care and explore symptom management, including cancer pain, anxiety, nausea, and insomnia among others. The possible benefits of cannabis psychoactivity will also be discussed, including harm reduction strategies for patients who wish to explore these effects. Cannabis and Cannabinoid-Based Medicines in Cancer Care: A Comprehensive Guide to Medical Management serves as a comprehensive text for oncologists, palliative care specialists, general practitioners, and nurse practitioners working with cancer patients or in palliative care settings.

ISBN: 9783030899189

Standard No.: 10.1007/978-3-030-89918-9doiSubjects--Topical Terms:

644638
Internal medicine.

LC Class. No.: RC1-1245

Dewey Class. No.: 616

Cannabis and Cannabinoid-Based Medicines in Cancer Care = A Comprehensive Guide to Medical Management /
LDR:03928nam a22003855i 4500 001 1094162
003 DE-He213
005 20220211122359.0
007 cr nn 008mamaa
008 221228s2022 sz | s |||| 0|eng d
020 $a 9783030899189 $9 978-3-030-89918-9
024 7 $a 10.1007/978-3-030-89918-9 $2 doi
035 $a 978-3-030-89918-9
050 4 $a RC1-1245
072 7 $a MJ $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJ $2 thema
082 0 4 $a 616 $2 23
100 1 $a Cyr, Claude. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1402249
245 1 0 $a Cannabis and Cannabinoid-Based Medicines in Cancer Care $h [electronic resource] : $b A Comprehensive Guide to Medical Management / $c by Claude Cyr, Mellar P. Davis, Danial Schecter, Paul Daeninck.
250 $a 1st ed. 2022.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a XXVII, 308 p. 8 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Overview of the Endocannabinoid System and Endocannabinoidome -- Cannabinoid-Based Medicine: Pharmacology and Drug Interactions -- Future Therapeutic Potential of Synthetic Cannabinoids and Endocannabinoid System Modulators -- Cannabis-Based Medicines as Anti-Cancer Agents -- Cannabinoid-Based Medicines and Cancer Symptom Management -- Patient Evaluation: Precautions and Managing Expectations -- Choosing a Product, Route of Administration, Initial Dosage, Titration, Monitoring and Management of Adverse Effects -- Psychoactive Effects of Cannabinoid-Based Medicines: Exploration and Inquiry.
520 $a The use of cannabinoid-based medicines (CBM), and cannabis in particular, has risen steadily among cancer and palliative care patients over the last few years. This textbook aims to address the multiple challenges facing healthcare providers regarding the use of CBM in this vulnerable patient population. It provides insight into the latest preclinical and clinical data and offers a practical approach on the use of CBM in a rapidly evolving landscape. It answers questions regarding the prescribing process and elucidates controversies regarding cannabis’ disease-modifying effects. The first chapters will review basic concepts of the endocannabinoid system and pharmacology of CBM, while focusing more specifically on the unique characteristics of two main cannabinoids: THC and CBD. Indicating which benefits can be expected from using either or both of these compounds, the book then addresses issues of drug-drug interactions and other challenges involved in prescribing CBM to frail patients with polypharmacy and multiple comorbidities. Comparing available products, both approved and non-approved by the FDA, the book discusses regional challenges for accessing reliably tested and labelled products in the context of standardization efforts. After carefully determining objectives and addressing patient expectations, further chapters will examine the different clinical settings in which CBM may be useful in cancer care and explore symptom management, including cancer pain, anxiety, nausea, and insomnia among others. The possible benefits of cannabis psychoactivity will also be discussed, including harm reduction strategies for patients who wish to explore these effects. Cannabis and Cannabinoid-Based Medicines in Cancer Care: A Comprehensive Guide to Medical Management serves as a comprehensive text for oncologists, palliative care specialists, general practitioners, and nurse practitioners working with cancer patients or in palliative care settings.
650 0 $a Internal medicine. $3 644638
650 0 $a Pain medicine. $3 790323
650 0 $a Palliative treatment. $3 564680
650 1 4 $a Internal Medicine. $3 668583
650 2 4 $a Pain Medicine. $3 669117
650 2 4 $a Palliative Care. $3 564685
700 1 $a Davis, Mellar P. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 863017
700 1 $a Schecter, Danial. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1402250
700 1 $a Daeninck, Paul. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1402251
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030899172
776 0 8 $i Printed edition: $z 9783030899196
856 4 0 $u https://doi.org/10.1007/978-3-030-89918-9
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)